Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
VO-Ohpic trihydrate
Cat. No.:
OB0225LY-0345
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by LC-MS.
Size:
Product Overview
Description:
VO-Ohpic trihydrateis a vanadium-containing compound with potential catalytic and biological activities.
Synonym:
VO-Ohpic; 476310-60-8
CAS No.:
476310-60-8
Compound CID:
66577002
Formula:
C12H9N2O8V·3H2O·H
Formula Weight:
415.2
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
VO-Ohpic trihydrate can act as a potent inhibitor of PTEN (phosphatase and tensin homolog).
Library Information
Targets:
PTEN
Pathways:
PI3K/Akt/mTOR signaling; Autophagy
Plate Number:
AOCL-5
Plate Location:
d9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
4.15 mg/mL; 10 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
